Co-convened by WHO, Gavi and the Government of South Africa - the Finance and Access Working Group was established in February 2025 to promote timely and equitable global access to affordably priced new TB vaccines. The working group coordinates efforts across governments, partners, financing institutions, private sector, and civil society to propose strategic partnerships, financing and procurement mechanisms, and market access solutions, with a particular focus on speeding up vaccine availability and access for high TB-burden countries.
